Pyxis Oncology price target raised to $8.00 from $7.00 by HC Wainwright
HC Wainwright & Co. raised its price target on Pyxis Oncology to $8.00 from $7.00. The firm maintained a Buy rating, per the TradingView News item relayed.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.